Matches in Wikidata for { <http://www.wikidata.org/entity/Q64114846> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q64114846 description "artículu científicu espublizáu en setiembre de 2019" @default.
- Q64114846 description "im Februar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q64114846 description "scientific article published on 01 September 2019" @default.
- Q64114846 description "wetenschappelijk artikel" @default.
- Q64114846 description "наукова стаття, опублікована в лютому 2019" @default.
- Q64114846 name "Attenuation of weight loss through improved antilipolytic effect in adipose tissue via the SGLT2 inhibitor tofogliflozin" @default.
- Q64114846 name "Attenuation of weight loss through improved antilipolytic effect in adipose tissue via the SGLT2 inhibitor tofogliflozin" @default.
- Q64114846 type Item @default.
- Q64114846 label "Attenuation of weight loss through improved antilipolytic effect in adipose tissue via the SGLT2 inhibitor tofogliflozin" @default.
- Q64114846 label "Attenuation of weight loss through improved antilipolytic effect in adipose tissue via the SGLT2 inhibitor tofogliflozin" @default.
- Q64114846 prefLabel "Attenuation of weight loss through improved antilipolytic effect in adipose tissue via the SGLT2 inhibitor tofogliflozin" @default.
- Q64114846 prefLabel "Attenuation of weight loss through improved antilipolytic effect in adipose tissue via the SGLT2 inhibitor tofogliflozin" @default.
- Q64114846 P1433 Q64114846-8DE8EE47-D15E-4F50-A3A5-46AF89EA4D54 @default.
- Q64114846 P1476 Q64114846-824A3B09-1598-48D9-A475-95D18BFD8E48 @default.
- Q64114846 P2093 Q64114846-175C0C7F-F330-44C7-977F-7FBFF1FC4D69 @default.
- Q64114846 P2093 Q64114846-3820CD4D-5A3B-48CD-92BD-DB27FAECE72A @default.
- Q64114846 P2093 Q64114846-68DF6743-016D-4305-9E8A-A4D948593E64 @default.
- Q64114846 P2093 Q64114846-7D4052E2-DDC9-4810-B30F-0463D7D930C9 @default.
- Q64114846 P2093 Q64114846-9B6092D0-17A0-4E7B-8511-9FF0A9E3D0D9 @default.
- Q64114846 P2093 Q64114846-B6E7B090-2692-4F10-8A22-CB528742D768 @default.
- Q64114846 P2093 Q64114846-B9FC17E4-E76E-4963-B96F-74B361AB2C7A @default.
- Q64114846 P2093 Q64114846-C21E998B-9251-49A6-A3E0-9A7C559759E9 @default.
- Q64114846 P2093 Q64114846-CFEC84C8-09CD-4D1F-840D-4ADDC8D456AC @default.
- Q64114846 P2093 Q64114846-E318EF0B-1D7C-4E7D-9B7E-C4E628BDF933 @default.
- Q64114846 P304 Q64114846-8A295BBC-8E0E-4E40-9A47-D29B8EB25C10 @default.
- Q64114846 P31 Q64114846-548EC16E-3263-4AA0-813C-8649D3F56E09 @default.
- Q64114846 P356 Q64114846-7FB494A4-767C-4CBD-B19B-74BC156E6159 @default.
- Q64114846 P407 Q64114846-51F88280-ABA7-411B-8D02-3AF1069C09E9 @default.
- Q64114846 P433 Q64114846-52E024D9-5744-46E5-9034-926C3646E676 @default.
- Q64114846 P478 Q64114846-10C79A6A-5A42-44C1-9B75-CFC490835015 @default.
- Q64114846 P577 Q64114846-258EA181-E2D1-4898-B33F-02DAD17FC965 @default.
- Q64114846 P698 Q64114846-C684BC78-1AA0-4194-9A54-828B96CC6524 @default.
- Q64114846 P356 JC.2018-02254 @default.
- Q64114846 P698 30811541 @default.
- Q64114846 P1433 Q3186902 @default.
- Q64114846 P1476 "Attenuation of Weight Loss Through Improved Antilipolytic Effect in Adipose Tissue Via the SGLT2 Inhibitor Tofogliflozin" @default.
- Q64114846 P2093 "Akihiro Yoshida" @default.
- Q64114846 P2093 "Hideki Suganami" @default.
- Q64114846 P2093 "Hirohito Sone" @default.
- Q64114846 P2093 "Kazuya Fujihara" @default.
- Q64114846 P2093 "Kohei Kaku" @default.
- Q64114846 P2093 "Masahiro Ishizawa" @default.
- Q64114846 P2093 "Shiro Tanaka" @default.
- Q64114846 P2093 "Takahiro Abe" @default.
- Q64114846 P2093 "Toshiaki Nojima" @default.
- Q64114846 P2093 "Yasuhiro Matsubayashi" @default.
- Q64114846 P304 "3647-3660" @default.
- Q64114846 P31 Q13442814 @default.
- Q64114846 P356 "10.1210/JC.2018-02254" @default.
- Q64114846 P407 Q1860 @default.
- Q64114846 P433 "9" @default.
- Q64114846 P478 "104" @default.
- Q64114846 P577 "2019-09-01T00:00:00Z" @default.
- Q64114846 P698 "30811541" @default.